- TSX-V:UVC
From visible illumination to ultraviolet disinfection, a single platform spanning every wavelength that matters.
Our Technology Platform
Comprehensive lighting solutions that save energy and protect health through mastery of the visible and ultraviolet spectrum.
Ultraviolet
99.7%
Pathogen Elimination
Revolutionary UV disinfection technology from proven upper-room GUV to breakthrough Far-UVC. Health Canada registered for human-safe pathogen elimination in occupied spaces.
SaniLume: Proven Upper-Room GUV, Health Canada Registered
SaniLux: Next-Generation Far-UVC, Safe for Humans and Occupied Spaces
Portable and HVAC-Integrated Disinfection Options
Validated Across Healthcare, Commercial, and Government Settings
Conventional Upper-Room GUV
254 nm
A controlled upper-room disinfection layer that targets airborne pathogens while occupied spaces continue operating below.
Next UV Light Space
216 nm
A next-generation Far-UVC platform designed for powerful disinfection within a precise wavelength zone.
Visible Light
34
of the Top 50 DLC fixtures
High-efficiency commercial lighting, proven at scale across retrofit and new construction.
Up to 167 lm/W luminous efficacy
60–75% energy reduction
DLC-certified, glare-controlled
One Continuous Spectrum
Better light. Better health. Better future.
Why Choose Us
One company, two complementary light technologies, measured in real-world impact.
Our Advantage
Technology Leadership Health Canada-registered GUV with a 70× Far-UVC power advantage and a deep diffused-LED portfolio.
Made in Canada 100% Ottawa manufacturing. No tariffs. Government procurement preference.
Regulatory Moats Only Health Canada-registered upper-room GUV device.
Strategic Backing Supported by Chris Anderson (TED) and Rob Reid through Resilience Reserve LLC.
Proudly partnering with top-tier clients to deliver industry-leading lighting solutions. Health Canada (in partnership with the NRC to help establish workplace 3.0 standards for Federal buildings).
Major Strategic Investment Announcement
Illumisoft has secured strategic investment from two of the world’s most influential voices in technology, media, and pandemic preparedness. Chris Anderson (Founder of TED) and Rob Reid (Creator of Rhapsody) have made a significant ownership commitment through their joint venture, Resilience Reserve LLC.
Ownership Stake
19.43%
Chris Anderson & Rob Reid
Chris Anderson
Founder & Curator of TED
“Illumisoft's existing and upcoming products promise to significantly dampen the spread of respiratory diseases in healthcare facilities, schools, and beyond. This could greatly enhance social resilience at all levels of global income.”
Rob Reid
Creator of Rhapsody · After On Podcast
“Illumisoft could soon revolutionize the use of tuned and targeted light as a weapon against disease.”
The Latest
illumi
May 5, 2026
Illumisoft (TSXV: UVC) provides a corporate update covering its TSX-V listing, SaniLume's Health Canada-registered upper-room UV platform, the SaniLux far-UVC program, the lighting division outlook, strategic investors, and leadership.
illumi
April 21, 2026
Illumisoft (TSXV:UVC) closed its three-cornered amalgamation with Claranova Technologies, completing its Qualifying Transaction. Common shares anticipated to begin trading April 23, 2026 under ticker UVC.
illumi
March 12, 2026
A Progressive Conservative source discusses why UV disinfection is about to become a ministry-level requirement for long-term-care facilities across the province.
Ready to reshape the spectrum
